Balgo, Troy

Balgo, Troy was paid $714K by Medicaid between Jan 2018 and Sep 2019, across 33 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 33% of everything it billed.

33Billing provider infoBALGO, TROY
ST.CLAIRSVILLE, OH 43950

33aNPI1104921949assigned 09/14/2006

33bProvider typeFamily Medicine Physician

28Total paid$714K

24GClaims42,756

24DCodes billed33

24AFirst – last monthJan 2018 – Sep 2019

Compared with peers

Next to other Family Medicine Physician providers in Ohio

Rank by total paid#86 of 739

Median peer was paid$30K

This provider vs. median24×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	20,183	$435K
2019	22,573	$279K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	33%	5,768	4,281	$236K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	25%	5,921	3,966	$177K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	24%	5,379	3,397	$169K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	1.8%	891	830	$13K
80346		1.3%	1,103	824	$10K
80361		1.1%	1,113	831	$8K
80362		<1%	888	662	$7K
83992		<1%	905	684	$5K
80354		<1%	1,111	832	$5K
80353		<1%	1,106	824	$5K
80358		<1%	1,097	820	$5K
80348		<1%	1,114	831	$5K

21 more codes

80369		<1%	1,109	$5K
80365		<1%	1,109	$5K
80373		<1%	1,088	$5K
80324		<1%	1,108	$4K
80359		<1%	1,109	$4K
80372		<1%	1,109	$4K
80356		<1%	1,110	$4K
80349		<1%	1,103	$4K
80355		<1%	952	$4K
99204	Doctor's office visit, new patient (more involved)	<1%	54	$4K
80360		<1%	987	$4K
80342		<1%	948	$4K
80335		<1%	1,137	$4K
80332		<1%	950	$4K
80366		<1%	883	$4K
80323		<1%	950	$3K
99213	Doctor's office visit, returning patient (routine)	<1%	84	$2K
81025		<1%	137	$2K
80320		<1%	143	$956.91
80345		<1%	144	$807.54
80339		<1%	146	$775.71

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.